Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Latini

Showing results (71-80 of 338) with videos related to

Pageof 34
Sort By:
Medicina (Kaunas, Lithuania)|August 28, 2019
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic ReviewLaura Orsolini, Stefania Chiappini, Umberto Volpe, et al.
Human Psychopharmacology|March 29, 2020
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapyLaura Orsolini, Stefania Chiappini, Duccio Papanti, et al.
Journal of Cardiac Failure|February 26, 2005
Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practiceAldo P Maggioni, Cristina Opasich, Inder Anand, et al.
European Journal of Heart Failure|January 3, 2006
Signs and symptoms in chronic heart failure: relevance of clinical trial results to point of care-data from Val-HeFTMaylene Wong, Lidia Staszewsky, Elisa Carretta, et al.
European Journal of Heart Failure|August 11, 2004
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failureLuigi Tavazzi, Gianni Tognoni, Maria Grazia Franzosi, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Post-cardiac arrest temporal evolution of left ventricular function in a rat model: speckle-tracking echocardiography and cardiac circulating biomarkersDaria De Giorgio, Davide Olivari, Francesca Fumagalli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 29, 2006
Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrenceMarcello Disertori, Roberto Latini, Aldo Pietro Maggioni, et al.
Journal of the American College of Cardiology|June 3, 2004
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic dataMaylene Wong, Lidia Staszewsky, Roberto Latini, et al.
Thrombosis Research|December 14, 2018
Low D-dimer levels in sepsis: Good or bad?Fabrizio Semeraro, Concetta T Ammollo, Pietro Caironi, et al.
Annals of Medicine|April 19, 2022
Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical eventsMarco Magnoni, Daniele Andreini, Angela Pirillo, et al.
Pageof 34

Showing results (71-80 of 338) with videos related to

Sort By:
Pageof 34
Medicina (Kaunas, Lithuania)|August 28, 2019
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic ReviewLaura Orsolini, Stefania Chiappini, Umberto Volpe, et al.
Human Psychopharmacology|March 29, 2020
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapyLaura Orsolini, Stefania Chiappini, Duccio Papanti, et al.
Journal of Cardiac Failure|February 26, 2005
Anemia in patients with heart failure: prevalence and prognostic role in a controlled trial and in clinical practiceAldo P Maggioni, Cristina Opasich, Inder Anand, et al.
European Journal of Heart Failure|January 3, 2006
Signs and symptoms in chronic heart failure: relevance of clinical trial results to point of care-data from Val-HeFTMaylene Wong, Lidia Staszewsky, Elisa Carretta, et al.
European Journal of Heart Failure|August 11, 2004
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failureLuigi Tavazzi, Gianni Tognoni, Maria Grazia Franzosi, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Post-cardiac arrest temporal evolution of left ventricular function in a rat model: speckle-tracking echocardiography and cardiac circulating biomarkersDaria De Giorgio, Davide Olivari, Francesca Fumagalli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 29, 2006
Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrenceMarcello Disertori, Roberto Latini, Aldo Pietro Maggioni, et al.
Journal of the American College of Cardiology|June 3, 2004
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic dataMaylene Wong, Lidia Staszewsky, Roberto Latini, et al.
Thrombosis Research|December 14, 2018
Low D-dimer levels in sepsis: Good or bad?Fabrizio Semeraro, Concetta T Ammollo, Pietro Caironi, et al.
Annals of Medicine|April 19, 2022
Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical eventsMarco Magnoni, Daniele Andreini, Angela Pirillo, et al.
Pageof 34